Medexus Pharmaceuticals (FRA:P731) Long-Term Debt : €28.1 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Medexus Pharmaceuticals Long-Term Debt?

Medexus Pharmaceuticals's Long-Term Debt for the quarter that ended in Jun. 2024 was €28.1 Mil.

Medexus Pharmaceuticals's quarterly Long-Term Debt declined from Dec. 2023 (€34.1 Mil) to Mar. 2024 (€31.4 Mil) and declined from Mar. 2024 (€31.4 Mil) to Jun. 2024 (€28.1 Mil).

Medexus Pharmaceuticals's annual Long-Term Debt declined from Mar. 2022 (€36.2 Mil) to Mar. 2023 (€25.6 Mil) but then increased from Mar. 2023 (€25.6 Mil) to Mar. 2024 (€31.4 Mil).

Medexus Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for Medexus Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Long-Term Debt Chart

Medexus Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Debt

Get a 7-Day Free Trial

25.89

28.82

36.15

25.57

31.42

Medexus Pharmaceuticals Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Long-Term Debt	Get a 7-Day Free Trial															23.48	22.24	34.12	31.42	28.11

Medexus Pharmaceuticals (FRA:P731) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medexus Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (FRA:P731) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

MEDXF:USA MDP:Canada

Address

35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Medexus Pharmaceuticals Headlines

No Headlines